December 23, 2003
I posted 3 rants on Neurontin in May and July – The whistle blower and Warner-Lambert, The Neurontin story, and More on Neurontin. These rants received many comments from angry users (who blame many side effects on these drugs. One of my guiding principles is to carefully look at the data rather than anecdotes. Thus, [...]
Read the full article →
December 22, 2003
There’s a Blurry Line Between Rx and O.T.C. The decision to sell a drug by prescription, experts say, may involve factors that have nothing to do with science or patient safety. Marketing and financial considerations, politics, doctors’ concerns and consumer psychology all may play a role. “Unequivocally, there is no bright line,” said Peter Barton [...]
Read the full article →